Healthcare provider profile · identity verified

Mufeedulla Khan, M.D.

Family Practice · INDEPENDENCE, OH · NPI 1760422406

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	418	83
Amlodipine Besylate	Amlodipine Besylate	285	66
Levothyroxine Sodium	Levothyroxine Sodium	262	64
Furosemide	Furosemide	228	57
Pantoprazole Sodium	Pantoprazole Sodium	227	59
Gabapentin	Gabapentin	220	54
Losartan Potassium	Losartan Potassium	171	36
Metoprolol Tartrate	Metoprolol Tartrate	164	43
Eliquis	Apixaban	162	32
Omeprazole	Omeprazole	152	34
Potassium Chloride	Potassium Chloride	150	36
Metoprolol Succinate	Metoprolol Succinate	131	31
Tamsulosin Hcl	Tamsulosin Hcl	129	37
Mirtazapine	Mirtazapine	128	30
Lisinopril	Lisinopril	119	33
Donepezil Hcl	Donepezil Hcl	116	23
Sertraline Hcl	Sertraline Hcl	110	37
Escitalopram Oxalate	Escitalopram Oxalate	100	28
Quetiapine Fumarate	Quetiapine Fumarate	86	23
Tramadol Hcl	Tramadol Hcl	86	36
Torsemide	Torsemide	85	19
Citalopram Hbr	Citalopram Hydrobromide	83	17
Trazodone Hcl	Trazodone Hcl	83	24
Allopurinol	Allopurinol	81	11
Xarelto	Rivaroxaban	80	13
Metformin Hcl	Metformin Hcl	78	21
Buspirone Hcl	Buspirone Hcl	77	18
Simvastatin	Simvastatin	74	19
Baclofen	Baclofen	73	16
Memantine Hcl	Memantine Hcl	72	16
Duloxetine Hcl	Duloxetine Hcl	65	13
Finasteride	Finasteride	63	14
Midodrine Hcl	Midodrine Hcl	56	13
Rosuvastatin Calcium	Rosuvastatin Calcium	56	15
Glimepiride	Glimepiride	54	11
Albuterol Sulfate Hfa	Albuterol Sulfate	53	19
Divalproex Sodium	Divalproex Sodium	52	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	50	suppressed
Famotidine	Famotidine	49	11
Clopidogrel	Clopidogrel Bisulfate	47	14
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Levetiracetam	Levetiracetam	43	suppressed
Meloxicam	Meloxicam	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	30
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	15
Nystatin	Nystatin	37	25
Spironolactone	Spironolactone	36	11
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Ozempic	Semaglutide	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Jardiance	Empagliflozin	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Lidocaine	Lidocaine	33	suppressed
Trospium Chloride	Trospium Chloride	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Cephalexin	Cephalexin	30	27
Doxycycline Hyclate	Doxycycline Hyclate	30	21
Warfarin Sodium	Warfarin Sodium	30	suppressed
Olanzapine	Olanzapine	29	suppressed
Prednisone	Prednisone	29	suppressed
Calcitriol	Calcitriol	28	suppressed
Risperidone	Risperidone	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	20
Verapamil Hcl	Verapamil Hcl	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Lorazepam	Lorazepam	20	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Folic Acid	Folic Acid	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Fluconazole	Fluconazole	15	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Combigan	Brimonidine Tartrate/Timolol	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Amantadine	Amantadine Hcl	13	suppressed
Atenolol	Atenolol	13	suppressed
Azithromycin	Azithromycin	13	12
Budesonide Dr	Budesonide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error